Caplin Point Laboratories has informed that the members of the company, at their meeting held today, had re-appointed C K Gariyali (DIN 08711546) as an independent director of the company for a further period of three years commencing from March 04, 2023. The details required under regulation 30 of SEBI Listing Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are enclosed as Annexure.
The above information is a part of company’s filings submitted to BSE.
